Back to UBS Group AG UBS Group AG

TRIBTRIB
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in TRINITY BIOTECH INVT LTD SPONS ADR NEW

UBS Group AG holds 1,107 shares of TRIB (TRINITY BIOTECH INVT LTD SPONS ADR NEW), worth $431 as of 2026-Q2. The position was increased (+9.9% shares).

Current Value

$431

Current Shares

1,107

Total Value Change

-$10,132

Total Shares Change

-4,071

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1,107
+9.9%
$4310.0%$0.39
8
2026-Q1
Increased
1,007
+29.1%
$5460.0%$0.54
10
2025-Q4
Increased
780
+1429.4%
$6170.0%$0.79
12
2025-Q3
New
51
-
$530.0%$1.04
17
2025-Q1
Exited
0
-100.0%
$00.0%$0.57
0
2024-Q4
New
10,621
-
$9,3460.0%$0.88
26
2024-Q2
Exited
0
-100.0%
$00.0%$2.13
0
2024-Q1
New
5,178
-
$10,5630.0%$2.04
26

Other major holders of TRIB: RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used